Re: [¹⁷⁷Lu]Lu-PSMA-617 plus Enzalutamide in Patients with Metastatic Castration-resistant Prostate Cancer (ENZA-p): An Open-label, Multicentre, Randomised, Phase 2 Trial

Eur Urol. 2025 Apr 22:S0302-2838(25)00207-6. doi: 10.1016/j.eururo.2025.04.006. Online ahead of print.

Authors

Juan Gómez Rivas¹, Jesús Moreno Sierra²

Affiliations

¹ Department of Urology, Research Institute, Hospital Clinico San Carlos, Madrid, Spain; Facultad de Medicina, Universidad Complutense de Madrid, Madrid, Spain. Electronic address: juangomezr@gmail.com.
² Department of Urology, Research Institute, Hospital Clinico San Carlos, Madrid, Spain; Facultad de Medicina, Universidad Complutense de Madrid, Madrid, Spain.

PMID: 40268591
DOI: 10.1016/j.eururo.2025.04.006

No abstract available